Glu-96 of Basic Fibroblast Growth Factor Is Essential for High Affinity Receptor Binding von Zhu, Hengyi, Ramnarayan, K., Anchin, Jerry, Miao, Wendy Y., Sereno, Arlene, Millman, Linda, Zheng, Jinhua, Balaji, V.N., Wolff, Manfred E.

Volltext

Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis von Zhu, H, Ramnarayan, K, Anchin, J, Miao, W Y, Sereno, A, Millman, L, Zheng, J, Balaji, V N, Wolff, M E

Volltext

Large-Scale Whole-Genome Sequencing of Three Diverse Asian Populations in Singapore von Wu, Degang, Dou, Jinzhuang, Bellis, Claire, Wilm, Andreas, Shih, Chih Chuan, Soon, Wendy Wei Jia, Khor, Chiea Chuen, DeGiorgio, Michael, Cheng, Shanshan, Bao, Li, Hwang, William Ying Khee, Davila, Sonia, Tan, Patrick, Moh, Angela, Foo, Jia Nee, Goh, Liuh Ling, Leong, Khai Pang, Foo, Roger S.Y., Lam, Carolyn Su Ping, Richards, Arthur Mark, Cheng, Ching-Yu, Wong, Tien Yin, Ng, Huck Hui, Ackers-Johnson, Matthew Andrew, Aliwarga, Edita, Ban, Kenneth Hon Kim, Chambers, John C., Chan, Dana Leng Hui, Chan, Cheryl Xue Li, Chee, Miao Ling, Chen, Yunxin, Chew, Elaine Guo Yan, Chew, Wen Jie, Chong, Jenny Pek Ching, Dorajoo, Rajkumar, Goh, Rick Siow Mong, Irwan, Ishak D., Jaufeerally, Fazlur, Jeyakani, Justin, Koh, John Tat Hung, Koh, Jia Yu, Krishnaswamy, Pavitra, Kuan, Jyn Ling, Kumari, Neelam, Lee, Ai Shan, Lee, Seow Eng, Lee, Yen Ling, Leong, See Ting, Li, Zheng, Liew, Jun Xian, Lim, Weng Khong, Lim, Chia Wei, Lim, Tingsen Benson, Lim, Choon Kiat, Lok, Au Wing, Chin, Calvin W.L., Majithia, Shivani, Maurer-Stroh, Sebastian, Meah, Wee Yang, Mok, Shi Qi, Ng, Pauline, Ng, Sarah B., Ng, Zhenyuan, Ng, Jessica Yan Xia, Ng, Ebonne, Nusinovici, Simon, Ong, Chin Thing, Pan, Bangfen, Pedergnana, Vincent, Poh, Stanley, Prabhakar, Shyam, Prakash, Kumar M., Sabanayagam, Charumathi, See, Wei Qiang, Sia, Yee Yen, Sim, Xueling, Sim, Wey Cheng, So, Jimmy, Soon, Dinna K.N., Tai, E. Shyong, Tan, Louis C.S., Tan, Hong Chang, Tan, Wilson Lek Wen, Tandiono, Moses, Tay, Amanda, Thakur, Sahil, Tham, Yih Chung, Tiang, Zenia, Toh, Grace Li-Xian, Tsai, Pi Kuang, Veeravalli, Lavanya, Wang, Ling, Wang, Min Rui, Wong, Wing-Cheong, Yeo, Khung Keong, Zhang, Liang, Zhai, Weiwei, Zhao, Yi, Liu, Jianjun, Wang, Chaolong

Volltext

Real-world characteristics and outcomes of patients with metastatic castration-resistant prostate cancer receiving chemotherapy versus androgen receptor-targeted therapy after fail... von Oh, William K., MD, Miao, Raymond, MS, Vekeman, Francis, MA, Sung, Jennifer, PharmD, MSc, MBA, Cheng, Wendy Y., MPH, MPhil, Gauthier-Loiselle, Marjolaine, PhD, Dhawan, Ravinder, PhD, Duh, Mei Sheng, ScD, MPH

Volltext

Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA... von Oh, William K., Cheng, Wendy Y., Miao, Raymond, Vekeman, Francis, Gauthier-Loiselle, Marjolaine, Duh, Mei Sheng, Drea, Edward, Szatrowski, Ted P.

Volltext

Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting von Oh, William K., Miao, Raymond, Vekeman, Francis, Sung, Jennifer, Cheng, Wendy Y., Gauthier-Loiselle, Marjolaine, Dhawan, Ravinder, Duh, Mei Sheng

Volltext

Real-world outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) chemotherapy (CT) vs alternative androgen receptor-tar... von Oh, William K., Cheng, Wendy Y., Miao, Raymond, Vekeman, Francis, Gauthier-Loiselle, Marjolaine, Duh, Mei Sheng, Drea, Edward, Szatrowski, Ted P.

Volltext

Clinical features and overall survival (OS) in patients (pts) with post-docetaxel (DTX) metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) therapy i... von Oh, William K., Miao, Raymond, Duh, Mei Sheng, Vekeman, Francis, Sung, Jennifer, Cheng, Wendy Y, Hennessy, Daniel, Gauthier-Loiselle, Marjolaine, Fortier, Jonathan, Dhawan, Ravinder

Volltext

DERIVADOS DE CROMANO 2,6-SUSTITUIDOS UTILES COMO AGONISTAS ADRENORECEPTORES BETA-3 von NING QL, JACQUES DUMAS, UDAY KHIRE, ROBERT DALLY, GAETAN H. LADOUCEUR, QUANRONG SHEN, DEREK B. LOWE, MING WANG, MIAO DAI, QINGJIE LIU, HOLIA N. HATOUM MOKDAD, TATIANA E. SHELEKHIN, STEVEN R. MAGNUSON, ROGER A. SMITH, WILLIAM H. BULLOCK, ANN-MARIE CAMPBELL, WENDY LEE, STEPHEN J. O CONNOR

Volltext bestellen